Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 15.65 Delayed Data As of Dec 02 |  +0.44 / +2.89%Today’s Change | 6.51 Today|||52-Week Range 20.88 | +60.18% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Brightstar Associates Llc |  Buy | 4/29/2022 | 1,478,978 | $10.00 | $14.8M | +54.64% |
Hoerter Steven L President & Chief Executive Officer |  Sale | 3/21/2022 | 3,150 | $9.11 | $28.7K | +76.44% |
Flynn Daniel L Chief Scientific Officer | Sale | 6/16/2022 | 1,768 | $10.75 | $19.0K | +43.32% |
Kelly Thomas P Chief Financial Officer | Sale | 6/16/2022 | 1,768 | $10.75 | $19.0K | +43.32% |
Sherman Matthew L Chief Medical Officer & Executive Vice President | Sale | 6/16/2022 | 1,768 | $10.75 | $19.0K | +43.32% |
Martin Daniel C Chief Commercial Officer | Sale | 6/16/2022 | 1,311 | $10.75 | $14.1K | +43.32% |
Pitman Jama Corporate Officer | Sale | 6/16/2022 | 1,298 | $10.75 | $14.0K | +43.32% |
Kelly Thomas P Chief Financial Officer | Sale | 2/16/2022 | 1,368 | $9.05 | $12.4K | +73.89% |
Flynn Daniel L Chief Scientific Officer | Sale | 2/16/2022 | 1,366 | $9.05 | $12.4K | +73.89% |
Pitman Jama Corporate Officer | Sale | 2/16/2022 | 1,146 | $9.05 | $10.4K | +73.89% |
Page of 3